Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Renee Welch"'
Autor:
Renee Welch, Ashley Riley
Publikováno v:
Transplantation and Cellular Therapy. 29:S86-S87
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7ae0776c33498a12d3d6a3ea138f441
https://doi.org/10.1016/s2666-6367(23)00178-1
https://doi.org/10.1016/s2666-6367(23)00178-1
Autor:
Meagan V. Lew, Yi Ren, Yen P. Lowder, Sharareh Siamakpour-Reihani, Sendhilnathan Ramalingam, Kristi M. Romero, Jillian C. Thompson, Lauren M. Bohannon, Jackie McIntyre, Helen Tang, Jolien Van Opstal, Ernaya Johnson, Harvey Jay Cohen, David B. Bartlett, Amy M. Pastva, Miriam Morey, Katherine S. Hall, Patrick Smith, Katherine B. Peters, Tamara J. Somers, Sarah Kelleher, Sophia K. Smith, Paul E. Wischmeyer, Pao-Hwa Lin, William A. Wood, Glynnis Thorpe, Kerry Minor, Kristi Wiggins, Therese Hennig, Tanya Helms, Renee Welch, Brittany Matthews, JoAnn Liu, Jill Burleson, Thomas Aberant, Ashley K. Engemann, Bethany Henshall, Maurisa Darby, Christina Proch, Michelle Dellascio, Alyssa Pittman, Jacob Suminguit, Taewoong Choi, Cristina Gasparetto, Gwynn D. Long, Richard D. Lopez, Stefanie Sarantopoulos, Mitchell E. Horwitz, Nelson J. Chao, Anthony D. Sung
Publikováno v:
Transplantation and cellular therapy. 28(8)
Allogeneic hematopoietic stem cell transplantation (HCT) is a potentially curative treatment for both malignant and nonmalignant hematologic diseases; however, reported rates of treatment-related mortality approach 30%. Outcomes are worse in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa3c14a24c1adde47bf53e7ea977a7ea
https://pubmed.ncbi.nlm.nih.gov/35595226
https://pubmed.ncbi.nlm.nih.gov/35595226
Autor:
Renee Welch, Kerry King Minor
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S384-S385
Topic Significance & Study Purpose/Background/Rationale Relapsed acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) or myeloproliferative neoplasm (MPN) following an allogeneic stem cell transplant has a bleak prognosis with no standard for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99488aa4fe04fda500a6eef322034451
https://doi.org/10.1016/j.bbmt.2019.12.141
https://doi.org/10.1016/j.bbmt.2019.12.141
Autor:
Cristina Gasparetto, Meagan V. Lew, Katherine S. Hall, Pao-Hwa Lin, Tanya Helms, Margaret Eren, Whitney Andrew, Renee Welch, Glynnis Thorpe, Stefanie Sarantopoulos, Ashley K. Engemann, Patrick Smith, Sophia K. Smith, Michelle Dellascio, Yen P. Lowder, Richard D. Lopez, Jillian C. Thompson, Anthony D. Sung, Thomas Aberant, Taewoong Choi, Sarah A. Kelleher, David A. Rizzieri, Harvey J. Cohen, Maurisa Darby, Brittany Matthews, Renea Valea, JoAnn Liu, Alyssa Pittman, Whitney Hicks, Tamara J. Somers, Therese Hennig, Kristi Romero, Yi Ren, David A. Bartlett, Amy M. Pastva, Bethany Henshall, Katherine B. Peters, Paul E. Wischmeyer, Rebecca Porter, Kristi Wiggins, Nelson J. Chao, Allison Adler, Miriam C. Morey, Mitchell E. Horwitz, Christina Proch, Lauren Bohannon, Kerry King Minor, Jill Burleson, Gwynn D. Long
Publikováno v:
Blood. 134:1984-1984
Introduction: Geriatric assessment (GA) is a multidimensional evaluation of patient health and function that may detect impairments not identified as part of routine care, predict treatment-related morbidity and mortality, and inform treatment plans.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6cd6589f752112b7bf17c4e8db97daa
https://doi.org/10.1182/blood-2019-127264
https://doi.org/10.1182/blood-2019-127264
Publikováno v:
Biology of Blood and Marrow Transplantation. 22(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a6ae17dd1bb01af5e365396611e4eef
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:S484-S485
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c65179494e1f3560b4bf4699b2ea78ee
https://doi.org/10.1016/j.bbmt.2016.12.590
https://doi.org/10.1016/j.bbmt.2016.12.590
Autor:
Erika Hamilton, Sarah S. Bacus, Christina I. Herold, Justin Favaro, P. Kelly Marcom, Bercedis L. Peterson, Renee Welch, Kimberly L. Blackwell, Gretchen Kimmick, Vijaya Chadaram, Judith O. Hopkins
Publikováno v:
Clinical Cancer Research. 17:6061-6070
Purpose: A phase II study of dasatinib, an inhibitor of multiple oncogenic tyrosine kinases including Src, was conducted to evaluate 16-week progression-free rate and tolerability in patients with previously treated metastatic breast cancer (MBC). Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfb2ce605f2691b25efb18b8d2a11c13
https://doi.org/10.1158/1078-0432.ccr-11-1071
https://doi.org/10.1158/1078-0432.ccr-11-1071
Autor:
Renee Welch, Krista Rowe-Nichols
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:S445
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::357a1329036db7262c7ca63e804ad892
https://doi.org/10.1016/j.bbmt.2017.12.716
https://doi.org/10.1016/j.bbmt.2017.12.716
Autor:
Carey, Anders, P Kelly, Marcom, Bercedis, Peterson, Lin, Gu, Sue, Unruhe, Renee, Welch, Peggy, Lyons, Millie, Behera, Susannah, Copland, Gretchen, Kimmick, Heather, Shaw, Stacey, Snyder, Monica, Antenos, Teresa, Woodruff, Kimberly, Blackwell
Publikováno v:
Cancer Investigation. 26:286-295
Premenopausal women treated for early stage breast cancer (ESBC) are at risk for chemotherapy-related amenorrhea (CRA). Prospectively-validated, predictive markers of CRA are needed.Premenopausal women with ESBC and planned chemotherapy (/= 25% risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d974346538425fa0b3aa3163c19475
https://doi.org/10.1080/07357900701829777
https://doi.org/10.1080/07357900701829777
Autor:
Gretchen Kimmick, S. Singh, Erika Hamilton, Paul K. Marcom, N. Desai, V. N. Trieu, K. L. Blackwell, V. Chadaram, Judith O. Hopkins, Renee Welch
Publikováno v:
Journal of Clinical Oncology. 28:1109-1109
1109 Background: Improved therapies and predictive markers are needed in TNBC. B (bevacizumab) and C combinations are active in many solid tumors, including TNBC. SPARC is an albumin-binding protein secreted by tumors, a potential target of nabP. Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a763fe64c6e87cf6dfbf361bb677ffa1
https://doi.org/10.1200/jco.2010.28.15_suppl.1109
https://doi.org/10.1200/jco.2010.28.15_suppl.1109